Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghazi M Rahman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Structure & Dynamics|March 27, 2014
Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domainGhazi M Rahman, Joydip Das
Chemical Reviews|November 7, 2014
C1 domains: structure and ligand-binding propertiesJoydip Das, Ghazi M Rahman
Bioorganic & Medicinal Chemistry|January 27, 2010
Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase CAnjoy Majhi, Ghazi M Rahman, Shyam Panchal, et al.
The Biochemical Journal|May 13, 2009
PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domainJoydip Das, Satyabrata Pany, Ghazi M Rahman, et al.
Bioorganic & Medicinal Chemistry|October 7, 2011
Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase CJoydip Das, Satyabrata Pany, Shyam Panchal, et al.
The Biochemical Journal|January 8, 2013
Identification of the activator-binding residues in the second cysteine-rich regulatory domain of protein kinase Cθ (PKCθ)Ghazi M Rahman, Sreejesh Shanker, Nancy E Lewin, et al.
Molecular Pharmacology|July 29, 2011
Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-κB-regulated gene expression and sensitization of tumor cells to chemotherapeutic agentsSubash C Gupta, Ramaswamy Kannappan, Jihye Kim, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Structure & Dynamics|March 27, 2014
Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domainGhazi M Rahman, Joydip Das
Chemical Reviews|November 7, 2014
C1 domains: structure and ligand-binding propertiesJoydip Das, Ghazi M Rahman
Bioorganic & Medicinal Chemistry|January 27, 2010
Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase CAnjoy Majhi, Ghazi M Rahman, Shyam Panchal, et al.
The Biochemical Journal|May 13, 2009
PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domainJoydip Das, Satyabrata Pany, Ghazi M Rahman, et al.
Bioorganic & Medicinal Chemistry|October 7, 2011
Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase CJoydip Das, Satyabrata Pany, Shyam Panchal, et al.
The Biochemical Journal|January 8, 2013
Identification of the activator-binding residues in the second cysteine-rich regulatory domain of protein kinase Cθ (PKCθ)Ghazi M Rahman, Sreejesh Shanker, Nancy E Lewin, et al.
Molecular Pharmacology|July 29, 2011
Bharangin, a diterpenoid quinonemethide, abolishes constitutive and inducible nuclear factor-κB (NF-κB) activation by modifying p65 on cysteine 38 residue and reducing inhibitor of nuclear factor-κB α kinase activation, leading to suppression of NF-κB-regulated gene expression and sensitization of tumor cells to chemotherapeutic agentsSubash C Gupta, Ramaswamy Kannappan, Jihye Kim, et al.
Pageof 1